ACRV stock news
This page provides real-time market news, earnings updates, and company announcements related to Acrivon Therapeutics, Inc. (ACRV).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-05-03 07:21 EST
Key Opinion Leader (KOL) Panel to Discuss Acrivon's ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress
Finviz2026-02-23 13:03:50
Acrivon Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
Finviz2026-02-24 13:06:44
Acrivon Therapeutics to Present Pre-Clinical AP3 Data at the 2026 AACR Annual Meeting Revealing Strong Synergy of ACR-368 with ADC Topo 1 Inhibitor Payloads and of both ACR-368 and ACR-2316 with Immune Checkpoint Inhibitors
Finviz2026-03-17 21:57:46
ACRV stock chart
ACRV stock detailsACRV stock price change
On the last trading day, ACRV stock closed at 2.09 USD, with a price change of 12.97% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more